Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Geng

Showing results (331-340 of 394) with videos related to

Pageof 40
Sort By:
Acta Pharmacologica Sinica|September 24, 2013
Energetic factors determining the binding of type I inhibitors to c-Met kinase: experimental studies and quantum mechanical calculationsZhe Yu, Yu-chi Ma, Jing Ai, et al.
Journal of Ethnopharmacology|June 26, 2024
Efficacy and mechanism of action of Yanxiao Di'naer formula for non-alcoholic steatohepatitis treatment based on metabolomics and RNA sequencingDong-Xuan Zheng, Qiang Hou, Tao-Tao Xue, et al.
Neurochemistry International|April 24, 2024
The Janus face of HIF-1α in ischemic stroke and the possible associated pathwaysNashwa Amin, Irum Naz Abbasi, Fei Wu, et al.
Stroke|April 5, 2017
Predictors for Symptomatic Intracranial Hemorrhage After Endovascular Treatment of Acute Ischemic StrokeYonggang Hao, Dong Yang, Huaiming Wang, et al.
Acta Pharmacologica Sinica|September 12, 2020
SAF-189s, a potent new-generation ROS1 inhibitor, is active against crizotinib-resistant ROS1 mutant-driven tumorsZong-Jun Xia, Yin-Chun Ji, De-Qiao Sun, et al.
Marine Drugs|August 28, 2024
Comparative Analysis of Tentacle Extract and Nematocyst Venom: Toxicity, Mechanism, and Potential Intervention in the Giant Jellyfish <i>Nemopilema nomurai</i>Xiao-Yu Geng, Ming-Ke Wang, Xiao-Chuan Hou, et al.
EMBO Reports|December 29, 2020
Histone acetyltransferase 1 is a succinyltransferase for histones and non-histones and promotes tumorigenesisGuang Yang, Ying Yuan, Hongfeng Yuan, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|January 7, 2018
Combination of 24-Hour and 7-Day Relative Neurological Improvement Strongly Predicts 90-Day Functional Outcome of Endovascular Stroke TherapyJie Pu, Huaiming Wang, Mingyi Tu, et al.
Acta Pharmacologica Sinica|January 20, 2022
PRMT5 confers lipid metabolism reprogramming, tumour growth and metastasis depending on the SIRT7-mediated desuccinylation of PRMT5 K387 in tumoursHong-Feng Yuan, Man Zhao, Li-Na Zhao, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 19, 2004
A genetic switch for epilepsy in adult miceHeinz E Krestel, Derya R Shimshek, Vidar Jensen, et al.
Pageof 40

Showing results (331-340 of 394) with videos related to

Sort By:
Pageof 40
Acta Pharmacologica Sinica|September 24, 2013
Energetic factors determining the binding of type I inhibitors to c-Met kinase: experimental studies and quantum mechanical calculationsZhe Yu, Yu-chi Ma, Jing Ai, et al.
Journal of Ethnopharmacology|June 26, 2024
Efficacy and mechanism of action of Yanxiao Di'naer formula for non-alcoholic steatohepatitis treatment based on metabolomics and RNA sequencingDong-Xuan Zheng, Qiang Hou, Tao-Tao Xue, et al.
Neurochemistry International|April 24, 2024
The Janus face of HIF-1α in ischemic stroke and the possible associated pathwaysNashwa Amin, Irum Naz Abbasi, Fei Wu, et al.
Stroke|April 5, 2017
Predictors for Symptomatic Intracranial Hemorrhage After Endovascular Treatment of Acute Ischemic StrokeYonggang Hao, Dong Yang, Huaiming Wang, et al.
Acta Pharmacologica Sinica|September 12, 2020
SAF-189s, a potent new-generation ROS1 inhibitor, is active against crizotinib-resistant ROS1 mutant-driven tumorsZong-Jun Xia, Yin-Chun Ji, De-Qiao Sun, et al.
Marine Drugs|August 28, 2024
Comparative Analysis of Tentacle Extract and Nematocyst Venom: Toxicity, Mechanism, and Potential Intervention in the Giant Jellyfish <i>Nemopilema nomurai</i>Xiao-Yu Geng, Ming-Ke Wang, Xiao-Chuan Hou, et al.
EMBO Reports|December 29, 2020
Histone acetyltransferase 1 is a succinyltransferase for histones and non-histones and promotes tumorigenesisGuang Yang, Ying Yuan, Hongfeng Yuan, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|January 7, 2018
Combination of 24-Hour and 7-Day Relative Neurological Improvement Strongly Predicts 90-Day Functional Outcome of Endovascular Stroke TherapyJie Pu, Huaiming Wang, Mingyi Tu, et al.
Acta Pharmacologica Sinica|January 20, 2022
PRMT5 confers lipid metabolism reprogramming, tumour growth and metastasis depending on the SIRT7-mediated desuccinylation of PRMT5 K387 in tumoursHong-Feng Yuan, Man Zhao, Li-Na Zhao, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 19, 2004
A genetic switch for epilepsy in adult miceHeinz E Krestel, Derya R Shimshek, Vidar Jensen, et al.
Pageof 40